Patients with completely resected stage IIB/C melanoma experienced significant and clinically meaningful improvements in recurrence-free survival following treatment with adjuvant nivolumab compared with placebo.
2022
Using Diagnostic Tools for Melanoma
At a session at the 2022 Fall Clinical Dermatology Conference, 2 clinicians discuss some of the top testing methods for skin cancer.
Neurofibromatosis Type 1 Linked to Greater Skin Cancer Risk
The risks of 4 types of skin cancers were investigated among patients who have neurofibromatosis type 1, a multisystem autosomal dominant genetic syndrome characterized by loss of neurofibromin.
Skin screenings may lead to increased biopsy rates, melanoma overdiagnosis
Individuals who undergo skin screenings experience higher rates of biopsies and melanoma, according to a study.